Plain-English translation of NCT04520126 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether Olivomed — an olive extract supplement — can help improve how your heart and blood vessels work in people with coronary artery disease. You would take capsules containing olive extract (or a placebo) for one month, then switch to the other treatment for another month. The researchers want to see if this natural supplement can protect your heart and blood vessels.
People with coronary artery disease need better ways to protect their heart and blood vessels beyond current treatments. This medication is being studied because olive extract contains compounds that may help improve blood vessel function and reduce heart disease risk.
You likely qualify if…
You likely don't qualify if…
You would take capsules twice a day for one month — either the olive extract or a placebo (inactive pill that looks the same). After one month, you would switch to the other treatment for another month. The study lasts about 2 months total, and researchers would check your heart and blood vessel function during visits to see if the treatment made a difference.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Greece
Sponsor
University of Athens
Enrollment target
~30 participants
Started
December 2020
Primary completion
April 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 70 Years
Last updated on clinicaltrials.gov in May 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ignatios Ikonomidis
2nd Cardiology Department, National and Kapodistrian University of Athens, Attikon General Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.